Thursday, June 23, 2016 10:33:08 AM
BY KELSIE SMITH WEDNESDAY, JUNE 22ND 2016
Click For News/Video
Geneseo, N.Y. - A new law in New York State aims at combating the heroin and opioid epidemic. Governor Andrew Cuomo signed the multifaceted legislation in Buffalo Wednesday morning.
In it, doctors will only be able to prescribe opioids for seven days, rather than 30.
As part of the 2016-2017 budget, the state will invest nearly $200 million for treatment services, including residential treatment beds.
Emergency treatment is extended from 48 to 72 hours.
Addicts will be able to seek immediate treatment rather than having to wait for insurance authorization.
Ann Domingos, the CEO of Council on Alcohol & Substance Abuse of Livingston County (CASA) tells us access to immediate treatment can make all the difference if someone is able to recover.
"For our clients, it's very crucial," said Domingos. "If they've reached the need for inpatient level of care, then they can't manage outside in an outpatient treatment, and every time someone continues to use, they could die."
CASA of Livingston County is also making its own changes.
It is working on offering a new opioid treatment, which could be what someone needs to make the difference in the success of their recovery.
"It will help the client be able to live their life with less restrictions," said Domingos.
The new treatment is an implant that goes under the skin just above the elbow. For a six month period the Titan Pharmaceuticals, Inc. device administers buprenorphine.
"They won't be tied to the medication like they used to be; clients will still need to come for treatment, but it won't be so intensive if they don't need it," said Domingos.
This helps diminish the effects of physical dependency to opioids. The implant will only be for clients in recovery who are stable.
"One of the things we found with patients that are not as stable is it's given them a motivation to really work hard at stabilization so they can get on the list for to receive this device," said Domingos.
Insurance will cover this device that Domingos hopes will be available to clients in the next few months.
Blessings to All
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent TTNP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM